APA

Utzschneider K. M., Tong J., Montgomery B., Udayasankar J., Gerchman F., Marcovina S. M., Watson C. E., Ligueros-Saylan M. A., Foley J. E., Holst J. J., Deacon C. F. & Kahn S. E. (20080116). The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose. : Diabetes care.

Chicago

Utzschneider Kristina M, Tong Jenny, Montgomery Brenda, Udayasankar Jayalakshmi, Gerchman Fernando, Marcovina Santica M, Watson Catherine E, Ligueros-Saylan Monica A, Foley James E, Holst Jens J, Deacon Carolyn F and Kahn Steven E. 20080116. The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose. : Diabetes care.

Harvard

Utzschneider K. M., Tong J., Montgomery B., Udayasankar J., Gerchman F., Marcovina S. M., Watson C. E., Ligueros-Saylan M. A., Foley J. E., Holst J. J., Deacon C. F. and Kahn S. E. (20080116). The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose. : Diabetes care.

MLA

Utzschneider Kristina M, Tong Jenny, Montgomery Brenda, Udayasankar Jayalakshmi, Gerchman Fernando, Marcovina Santica M, Watson Catherine E, Ligueros-Saylan Monica A, Foley James E, Holst Jens J, Deacon Carolyn F and Kahn Steven E. The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose. : Diabetes care. 20080116.